health news today obesity drugs glp-1 The revolution: What UAB researchers are discovering about how these work GLP-1 medicines entered clinical use
Description
Key Takeaways In 2024, the market for GLP-1 receptor agonist generated a revenue of US$ 53.5 billion , with a CAGR of 17.5% , and is expected to reach US$ 268.4 billion by the year 2033
doi: 10.1016/j.drudis.2016.01.013 [DOI] [PubMed] [Google Scholar] 65
DBP, diastolic blood pressure
Potential liver benefits: Early data suggest improvements in fatty liver disease , which is becoming one of the most common health threats worldwide
To properly discuss these concerns, its important to first understand how GLP-1 drugs actually work
GLP-1R and Diabetes GLP-1R Structure and Function Glucagon like peptide-1 receptor (GLP-1R) is a member of the Class B GPCR family (1)
